STEMXCELL
DEAD

Serial Number

90750083

Owner

PrimeGen US, Inc.

Attorney

Alexis Crawford Douglas

Filing Date

Jun 2, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STEMXCELL Trademark

Serial Number: 90750083

STEMXCELL is a trademark filed by PrimeGen US, Inc. on June 2, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PrimeGen US, Inc. (4 trademarks)

Santa Ana, CA 92705

Entity Type: 03

Trademark Details

Filing Date

June 2, 2021

Registration Date

Not Registered

Goods & Services

Stem cells for medical or veterinary use; activated mesenchymal stem cells for medical or veterinary use; non-activated mesenchymal stem cells for medical or veterinary use; therapeutic pharmaceuticals comprised of stem cells for the treatment of liver disease, kidney disease, heart disease, wound healing and osteoarthritis, and for the treatment of immune system related diseases and disorders; injectable pharmaceuticals comprised of stem cells for the treatment of liver disease, kidney disease, heart disease, wound healing and osteoarthritis, and for the treatment of immune system related diseases and disorders; cytokines produced by stem cells, including in culture media, for use as injectables for medical or veterinary use; stem cells combined with other added cytokines, inhibitors, or small molecules for use as injectables for medical or veterinary use

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 1, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 1, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 1, 2023 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 15, 2022 GNFN
FINAL REFUSAL E-MAILED
Aug 15, 2022 GNFR
FINAL REFUSAL WRITTEN
Aug 15, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 18, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2021 NWOS
NEW APPLICATION ENTERED
Jun 5, 2021 NWAP